@morganp
Where did you get the idea they were going to announce each contract win?
Most businesses give you a quarterly update, which is what we will need to come to expect with FLC going forward.
There has been a raft of announcements on contract wins early on post-merger, possibly due to the downward pressure on the share price. But I don't expect this to continue as FLC is not a 'spec' play anymore, it is a 'growth' business that should focus on growing the business and not justifying itself through over-disclosure.
I already believe there has been more than enough evidence that there is traction in the market for our products e.g.
6 Nov 17 - First C-MABR contract in China
30 Oct 17 - First inland USA MABR to be commissioned
24 Oct 17 - First wastewater re-use plant in the fish processing industry in Ecuador
23 Oct 17 - Another Nirobox contract awarded
9 Oct 17 - First SUBRE contract win
14 Sep 17 - Africa MOU for US$100m contract
That is a pretty solid set of announcements, one for each key product line in our business.
It should also be noted that in the 10 Oct 17 investor presentation, it was noted on page 8 that US$9m of new bookings were booked globally since the EGM in July17. They sure as well didn't announce US$9m of sales on the ASX, it was done through BAU (business as usual).
So I personally expect FLC to focus on runnings its business and let the quarterly business updates give us guidance, with the occasional significant contract win/operational update being announced on the ASX.
Sell side volume still looking thin ... we haven't seen two green days in a row for a very long time, still on track for a green candle this week!
Good luck!
FLC
fluence corporation limited
Add to My Watchlist
3.23%
!
6.0¢

Chart, page-1974
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.0¢ |
Change
-0.002(3.23%) |
Mkt cap ! $64.85M |
Open | High | Low | Value | Volume |
6.1¢ | 6.1¢ | 6.0¢ | $7.405K | 123.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 109000 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 36971 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 109000 | 0.057 |
1 | 52649 | 0.056 |
1 | 40000 | 0.055 |
1 | 200000 | 0.052 |
1 | 18700 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 36971 | 1 |
0.065 | 4878 | 1 |
0.068 | 135075 | 2 |
0.078 | 128268 | 1 |
0.080 | 205900 | 6 |
Last trade - 15.15pm 27/02/2025 (20 minute delay) ? |
Featured News
FLC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
SPONSORED BY The Market Online